News

FDA Approves Genzyme’s AUBAGIO® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis

AUBAGIO (R) 14mg
AUBAGIO (R) 14mg

Download

infoBox